MRKR Q3'26 Earnings: revenue estimate is 2.12M USD
1분 미만 읽기
MRKR (Marker Therapeutics, Inc.) is set to announce its Q3'26 results on November 05, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).
For Q3'26, revenue estimate is 2.12 million USD with EPS (earnings per share) anticipated at (0.12) USD. Learn more details at MRKR Financials page.
Revenue & EPS values are provided in USD
| Q3'25 | Q4'25 | Q1'26 | Q2'26 | Q3'26 | |
|---|---|---|---|---|---|
| Revenue Reported | 1.23 M | 1.10 M | 800.00 K | 700.00 K | — |
| Revenue Estimate | 723.00 K | 682.10 K | 783.90 K | 660.67 K | 2.12 M |
| Revenue Surprise | +70.53% | +61.27% | +2.05% | +5.95% | |
| EPS Reported | (0.12) | (0.10) | (0.16) | (0.09) | |
| EPS Estimate | (0.36) | (0.19) | (0.16) | (0.13) | (0.12) |
| EPS Surprise | +66.67% | +47.58% | +0.00% | +29.13% |
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.